Active substance
Ciclopirox
- US FDA 32
- Health Canada 2
- US price lines 10
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| LOPROX | 0.77% | cream · topical | EUROFARMA | Prescription | 30 Dec 1982 |
| LOPROX | 0.77% | suspension · topical | EUROFARMA | Prescription | 30 Dec 1988 |
| CICLOPIROX | 0.77% | suspension · topical | FOUGERA PHARMS | Prescription | 6 Aug 2004 |
| CICLOPIROX | 0.77% | cream · topical | FOUGERA PHARMS | Prescription | 29 Dec 2004 |
| CICLOPIROX | 0.77% | cream · topical | SUN PHARMA CANADA | Prescription | 12 Apr 2005 |
| CICLOPIROX | 0.77% | cream · topical | PADAGIS ISRAEL | Prescription | 3 Mar 2006 |
| CICLOPIROX | 0.77% | suspension · topical | PADAGIS ISRAEL | Prescription | 15 Dec 2006 |
| CICLOPIROX | 8% | solution · topical | PADAGIS US | Prescription | 18 Sep 2007 |
| CICLOPIROX | 8% | solution · topical | ENCUBE | Prescription | 18 Sep 2007 |
| CICLOPIROX | 8% | solution · topical | CHARTWELL RX | Prescription | 18 Sep 2007 |
| CICLOPIROX | 8% | solution · topical | RISING | Prescription | 18 Sep 2007 |
| CICLOPIROX | 8% | solution · topical | ACELLA | Prescription | 18 Sep 2007 |
| CICLOPIROX | 0.77% | gel · topical | FOUGERA PHARMS | Prescription | 10 Jun 2008 |
| CICLOPIROX | 0.77% | gel · topical | PADAGIS US | Prescription | 7 Jan 2009 |
| CICLOPIROX | 0.77% | cream · topical | GLENMARK PHARMS | Prescription | 10 Nov 2009 |
| CICLOPIROX | 1% | shampoo · topical | ACTAVIS MID ATLANTIC | Prescription | 24 Nov 2009 |
| CICLOPIROX | 1% | shampoo · topical | PADAGIS US | Prescription | 16 Feb 2010 |
| CICLOPIROX | 1% | shampoo · topical | FOUGERA PHARMS | Prescription | 25 May 2010 |
| CICLOPIROX | 0.77% | cream · topical | COSETTE PHARMS NC | Prescription | 20 Dec 2010 |
| CICLOPIROX | 1% | shampoo · topical | SUN PHARMA CANADA | Prescription | 23 Feb 2011 |
| CICLOPIROX | 0.77% | gel · topical | GLENMARK PHARMS | Prescription | 29 Feb 2012 |
| CICLOPIROX | 1% | shampoo · topical | ENCUBE | Prescription | 5 Apr 2018 |
| CICLOPIROX | 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | gel · topical | ALVOGEN | Discontinued | 21 Jul 1997 |
| PENLAC | 8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution · topical | VALEANT BERMUDA | Discontinued | 17 Dec 1999 |
| LOPROX | 1% | shampoo · topical | BAUSCH | Discontinued | 28 Feb 2003 |
7 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-CICLOPIROX | 02298953 | 8 % / W/W | SOLUTION · TOPICAL | APOTEX INC |
| TARO-CICLOPIROX | 02353288 | 8 % / W/W | SOLUTION · TOPICAL | TARO PHARMACEUTICALS INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CICLOPIROX 0.77% CREAM | $0.20766 | per GM | 23 Sep 2026 |
| US NADAC | CICLOPIROX 0.77% CREAM | $0.1025 | per GM | 23 Sep 2026 |
| US NADAC | CICLOPIROX 0.77% CREAM | $0.16869 | per GM | 23 Sep 2026 |
| US NADAC | CICLOPIROX 0.77% GEL | $0.76886 | per GM | 23 Sep 2026 |
| US NADAC | CICLOPIROX 0.77% GEL | $0.84751 | per GM | 23 Sep 2026 |
| US NADAC | CICLOPIROX 0.77% GEL | $0.78726 | per GM | 23 Sep 2026 |
| US NADAC | CICLOPIROX 0.77% TOPICAL SUSP | $0.7215 | per ML | 23 Sep 2026 |
| US NADAC | CICLOPIROX 0.77% TOPICAL SUSP | $0.80936 | per ML | 23 Sep 2026 |
| US NADAC | CICLOPIROX 1% SHAMPOO | $0.2108 | per ML | 23 Sep 2026 |
| US NADAC | CICLOPIROX 8% SOLUTION | $1.15412 | per ML | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.